¶ NPAS4 Protein — Neuronal PAS Domain Protein 4
| NPAS4 Protein |
|---|
| Gene | [NPAS4](/genes/npas4) |
| UniProt ID | [Q8NHW6](https://www.uniprot.org/uniprot/Q8NHW6) |
| Molecular Weight | ~102 kDa |
| Subcellular Localization | Nucleus, transcription factor |
| Protein Family | bHLH-PAS transcription factor family |
| PDB Structures | [4DXL](https://www.ebi.ac.uk/pdbe/entry/pdb/4dxl), [5SY5](https://www.ebi.ac.uk/pdbe/entry/pdb/5sy5) |
NPAS4 (Neuronal PAS Domain Protein 4) is an activity-dependent transcription factor that plays a critical role in neuronal survival, synaptic plasticity, and cognitive function. It is induced by neuronal activity and BDNF signaling, and regulates the expression of genes essential for synaptic formation and neuroprotection.
NPAS4 is a bHLH-PAS transcription factor:
- Basic helix-loop-helix (bHLH) domain: DNA binding
- PAS-A domain: Protein-protein interactions
- PAS-B domain: Ligand binding, dimerization
- Transactivation domain: At C-terminus, recruits coactivators
NPAS4 forms homodimers or heterodimers with other bHLH-PAS proteins to bind specific DNA sequences (XREs and E-boxes).
NPAS4 performs critical activity-dependent functions:
- Activity-dependent transcription: Rapidly induced by neuronal firing
- Synaptic plasticity: Regulates formation of inhibitory synapses
- Neuroprotection: Protects neurons from excitotoxicity
- Learning and memory: Essential for memory consolidation
- Homeostatic regulation: Balances excitatory/inhibitory signaling
NPAS4 is expressed primarily in neurons throughout the brain, with highest expression in the hippocampus and cortex. It is induced by synaptic activity, seizures, and BDNF.
NPAS4 is dysregulated in AD and contributes to disease pathology:
- Synaptic deficits: Loss of NPAS4 affects inhibitory synapse formation
- Memory impairment: NPAS4 is required for memory consolidation
- Neuronal survival: Reduced neuroprotection in AD
- Therapeutic potential: Restoring NPAS4 may improve cognitive function
- Protects dopaminergic neurons from toxicity
- Modulates alpha-synuclein-induced neurodegeneration
- Activity-dependent neuroprotection
¶ Stroke and Brain Injury
- Induced by ischemic preconditioning
- Provides neuroprotection against stroke
- Promotes functional recovery
- NPAS4 polymorphisms associated with schizophrenia risk
- Altered inhibitory synapse function
- Cognitive deficits linked to NPAS4 dysregulation
NPAS4 is a promising therapeutic target:
- Small molecule activators: Compounds that enhance NPAS4 expression
- Gene therapy: AAV-mediated NPAS4 delivery
- BDNF mimetics: Activate upstream NPAS4 signaling
- Epigenetic approaches: Modulate NPAS4 promoter activity
NPAS4 interacts with multiple partners:
- ARNT2: Dimerization partner in neurons
- CREB: Coactivates shared target genes
- BDNF/TrkB signaling: Upstream activator
- Bcl-2 family: Regulates anti-apoptotic genes
- GABAergic synapse proteins: Direct transcriptional targets
- NPAS4 regulates inhibitory synapse formation (2019)
- Activity-dependent neuroprotection by NPAS4 (2020)
- NPAS4 in Alzheimer's disease models (2021)
- NPAS4 and memory consolidation (2022)
- Transcription factor networks in neurodegeneration (2023)